Puja Sapra PhD

Puja Sapra is Senior Director at the Oncology Research Unit, Pfizer where she oversees preclinical development of all antibody drug conjugate therapeutic programs. Prior to joining Pfizer, she led Pharmacology groups at Enzon Pharmaceuticals and Immunomedics Inc. and developed oncology-based drugs that are undergoing clinical evaluation.

Puja Sapra received a Bachelors degree from All India Institute of Medical Sciences, an MS in Pharmacology from UK and a PhD in Pharmacology from University of Alberta, Canada. Since PhD she has developed various therapeutic modalities including antibodies, antibody-drug conjugates, pegylated drugs, nanoparticles and antisense oligonucleotides.